fidel Transfidelity
$ 0.6251
0.05557 BTC
557 satoshies
Date ATH: 20 September, 2025
(4 days ago)
Market Cap
625,190 $
24 Hour Trading Vol
66,053.7297 $
Circulating Supply
1,00 MLN.
Total Supply
1,00 MLN.
Max Supply
1,00 MLN.
Fully Diluted Valuation
556,822 $
Low
Range
High
Info
1h
24h
7d
1m
1y
max
0%
0%
0%
0%
0%
0%
Transfidelity Price Statistics
0.6251 $
0.549 $ / 0.8599 $
66,053.7297 $
#4841
625,190 $
0.8599 $
-27.3%
20 September, 2025, (4 days ago)
0.5344 $
16.97%
01 September, 2025, (23 days ago)
Transfidelity Top Markets
#
Exchange
Pair
Trust Score
Transfidelity Performance
Trading Pair
day
week
month
fidel
/
usd
-5.84%
-13.9%
-5.77%
fidel
/
btc
-5.28%
-10.39%
-8.39%
fidel
/
eth
-4.54%
-6.48%
1.47%
About Coin
Neurodegenerative diseases such as Alzheimer's Disease are devastating conditions that impact millions globally. These diseases are driven by the misfolding and aggregation of proteins, which lead to brain cell death and cognitive decline. To make matters worse, as we age our cells become more error-prone, resulting in more errors during protein printing, causing proteins to clump together and form aggregates.
Project Transfidelity aims to solve this by improving the accuracy of protein printing, preventing toxic aggregates from forming. Led by Dr. Dimitri Scherbakov and Dr. Rashid Akbergenov, with over 50 years of combined experience in the lab, we have identified two molecules that may improve the efficiency of protein production, potentially preventing protein aggregates, hypothesized to cause dementia.
Despite the significant research funding allocated to neurodegenerative diseases, current therapies continue to treat the symptoms caused by the protein aggregates, with little progress made to stop or reverse disease. We’re trying to go after a potential root cause - rather than trying to clear aggregates once they are there, we aim to prevent them from forming in the first place by reducing the production of faulty proteins. With a clear path towards developing novel intellectual property (IP) and an ever-growing target market, we believe we are poised to make an impact on neurodegenerative disorders and the way we age.
Where is Transfidelity available for purchase?
You can exchange FIDEL tokens on both decentralized and centralized crypto platforms. The favored choice for purchasing and trading Transfidelity is Uniswap V3 (Base), notably the FIDEL/FIDEL pair, which saw a trading volume of $ 36,034 in the past day.
What is the highest value Transfidelity (FIDEL) has ever reached?
Transfidelity (FIDEL) reached its peak price at 0.8599 $ on 20 September 2025, approximately 4 days ago ago. Presently, the current price is -27.3% lower than this all-time high.
What is the historical minimum price for Transfidelity (FIDEL)?
The minimum price reached for Transfidelity (FIDEL) was 0.5344 $, documented on 01 September 2025, more than 23 days ago. In comparison, the current price is 16.97%, it above this historical low.
What is the fully diluted valuation of Transfidelity (FIDEL)?
The fully diluted valuation (FDV) of Transfidelity (FIDEL) stands at $ 556,822. This figure reflects the maximum potential market capitalization, considering that the current circulating supply is at its maximum of 1,000,000 FIDEL tokens. The realization of this FDV might take several years depending on the emission schedule of FIDEL tokens.
IMPORTANT DISCLAIMER:
The information presented on our website and associated platforms is sourced from third parties and is intended for general informational purposes only. We do not guarantee the accuracy or timeliness of this content. None of the information provided should be construed as financial, legal, or other professional advice tailored to your specific needs. Your use of this content is at your own discretion and risk. It's important to independently research, evaluate, and verify the information before relying on it. Trading carries significant risks, so it's advisable to consult with a financial advisor before making any decisions. Our content is not intended to solicit or offer any services.